IBDEI03G ; ; 09-FEB-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4171,1,3,0)
 ;;=3^Athscl Hrt Disease of Transplanted Hrt w/o Ang Pctrs
 ;;^UTILITY(U,$J,358.3,4171,1,4,0)
 ;;=4^I25.811
 ;;^UTILITY(U,$J,358.3,4171,2)
 ;;=^5007142
 ;;^UTILITY(U,$J,358.3,4172,0)
 ;;=I25.812^^20^190^2
 ;;^UTILITY(U,$J,358.3,4172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4172,1,3,0)
 ;;=3^Athscl Bypass Cor Art of Transplanted Hrt w/o Ang Pctrs
 ;;^UTILITY(U,$J,358.3,4172,1,4,0)
 ;;=4^I25.812
 ;;^UTILITY(U,$J,358.3,4172,2)
 ;;=^5007143
 ;;^UTILITY(U,$J,358.3,4173,0)
 ;;=I35.0^^20^190^10
 ;;^UTILITY(U,$J,358.3,4173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4173,1,3,0)
 ;;=3^Nonrhematic Aortic Valve Stenosis
 ;;^UTILITY(U,$J,358.3,4173,1,4,0)
 ;;=4^I35.0
 ;;^UTILITY(U,$J,358.3,4173,2)
 ;;=^5007174
 ;;^UTILITY(U,$J,358.3,4174,0)
 ;;=I35.1^^20^190^13
 ;;^UTILITY(U,$J,358.3,4174,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4174,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,4174,1,4,0)
 ;;=4^I35.1
 ;;^UTILITY(U,$J,358.3,4174,2)
 ;;=^5007175
 ;;^UTILITY(U,$J,358.3,4175,0)
 ;;=I35.2^^20^190^14
 ;;^UTILITY(U,$J,358.3,4175,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4175,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis w/ Insufficiency
 ;;^UTILITY(U,$J,358.3,4175,1,4,0)
 ;;=4^I35.2
 ;;^UTILITY(U,$J,358.3,4175,2)
 ;;=^5007176
 ;;^UTILITY(U,$J,358.3,4176,0)
 ;;=I35.8^^20^190^11
 ;;^UTILITY(U,$J,358.3,4176,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4176,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorders
 ;;^UTILITY(U,$J,358.3,4176,1,4,0)
 ;;=4^I35.8
 ;;^UTILITY(U,$J,358.3,4176,2)
 ;;=^5007177
 ;;^UTILITY(U,$J,358.3,4177,0)
 ;;=I35.9^^20^190^12
 ;;^UTILITY(U,$J,358.3,4177,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4177,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorders,Unspec
 ;;^UTILITY(U,$J,358.3,4177,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,4177,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,4178,0)
 ;;=I48.91^^20^190^5
 ;;^UTILITY(U,$J,358.3,4178,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4178,1,3,0)
 ;;=3^Atrial Fibrillation,Unspec
 ;;^UTILITY(U,$J,358.3,4178,1,4,0)
 ;;=4^I48.91
 ;;^UTILITY(U,$J,358.3,4178,2)
 ;;=^5007229
 ;;^UTILITY(U,$J,358.3,4179,0)
 ;;=I49.9^^20^190^6
 ;;^UTILITY(U,$J,358.3,4179,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4179,1,3,0)
 ;;=3^Cardiac Arrhythmia,Unspec
 ;;^UTILITY(U,$J,358.3,4179,1,4,0)
 ;;=4^I49.9
 ;;^UTILITY(U,$J,358.3,4179,2)
 ;;=^5007237
 ;;^UTILITY(U,$J,358.3,4180,0)
 ;;=I50.9^^20^190^8
 ;;^UTILITY(U,$J,358.3,4180,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4180,1,3,0)
 ;;=3^Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,4180,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,4180,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,4181,0)
 ;;=I73.9^^20^190^16
 ;;^UTILITY(U,$J,358.3,4181,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4181,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,4181,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,4181,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,4182,0)
 ;;=I87.2^^20^190^18
 ;;^UTILITY(U,$J,358.3,4182,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4182,1,3,0)
 ;;=3^Venous Insufficiency,Chronic
 ;;^UTILITY(U,$J,358.3,4182,1,4,0)
 ;;=4^I87.2
 ;;^UTILITY(U,$J,358.3,4182,2)
 ;;=^5008047
 ;;^UTILITY(U,$J,358.3,4183,0)
 ;;=R07.9^^20^190^7
 ;;^UTILITY(U,$J,358.3,4183,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4183,1,3,0)
 ;;=3^Chest Pain,Unspec
 ;;^UTILITY(U,$J,358.3,4183,1,4,0)
 ;;=4^R07.9
 ;;^UTILITY(U,$J,358.3,4183,2)
 ;;=^5019201
 ;;^UTILITY(U,$J,358.3,4184,0)
 ;;=E03.9^^20^191^16
 ;;^UTILITY(U,$J,358.3,4184,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4184,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,4184,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,4184,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,4185,0)
 ;;=E11.9^^20^191^8
 ;;^UTILITY(U,$J,358.3,4185,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4185,1,3,0)
 ;;=3^Diabetes Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,4185,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,4185,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,4186,0)
 ;;=E10.9^^20^191^5
 ;;^UTILITY(U,$J,358.3,4186,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4186,1,3,0)
 ;;=3^Diabetes Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,4186,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,4186,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,4187,0)
 ;;=E11.65^^20^191^7
 ;;^UTILITY(U,$J,358.3,4187,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4187,1,3,0)
 ;;=3^Diabetes Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,4187,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,4187,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,4188,0)
 ;;=E10.65^^20^191^4
 ;;^UTILITY(U,$J,358.3,4188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4188,1,3,0)
 ;;=3^Diabetes Type 1 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,4188,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,4188,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,4189,0)
 ;;=E11.8^^20^191^6
 ;;^UTILITY(U,$J,358.3,4189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4189,1,3,0)
 ;;=3^Diabetes Type 2 w/ Complications,Unspec
 ;;^UTILITY(U,$J,358.3,4189,1,4,0)
 ;;=4^E11.8
 ;;^UTILITY(U,$J,358.3,4189,2)
 ;;=^5002665
 ;;^UTILITY(U,$J,358.3,4190,0)
 ;;=E10.8^^20^191^3
 ;;^UTILITY(U,$J,358.3,4190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4190,1,3,0)
 ;;=3^Diabetes Type 1 w/ Complications,Unspec
 ;;^UTILITY(U,$J,358.3,4190,1,4,0)
 ;;=4^E10.8
 ;;^UTILITY(U,$J,358.3,4190,2)
 ;;=^5002625
 ;;^UTILITY(U,$J,358.3,4191,0)
 ;;=E53.8^^20^191^24
 ;;^UTILITY(U,$J,358.3,4191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4191,1,3,0)
 ;;=3^Vitamin B Group Deficiency
 ;;^UTILITY(U,$J,358.3,4191,1,4,0)
 ;;=4^E53.8
 ;;^UTILITY(U,$J,358.3,4191,2)
 ;;=^5002797
 ;;^UTILITY(U,$J,358.3,4192,0)
 ;;=E78.5^^20^191^15
 ;;^UTILITY(U,$J,358.3,4192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4192,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,4192,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,4192,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,4193,0)
 ;;=E66.9^^20^191^22
 ;;^UTILITY(U,$J,358.3,4193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4193,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,4193,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,4193,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,4194,0)
 ;;=E66.01^^20^191^21
 ;;^UTILITY(U,$J,358.3,4194,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4194,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,4194,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,4194,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,4195,0)
 ;;=E66.3^^20^191^23
 ;;^UTILITY(U,$J,358.3,4195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4195,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,4195,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,4195,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,4196,0)
 ;;=D50.9^^20^191^17
 ;;^UTILITY(U,$J,358.3,4196,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4196,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,4196,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,4196,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,4197,0)
 ;;=D64.9^^20^191^2
 ;;^UTILITY(U,$J,358.3,4197,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4197,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,4197,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,4197,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,4198,0)
 ;;=D68.318^^20^191^14
 ;;^UTILITY(U,$J,358.3,4198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4198,1,3,0)
 ;;=3^Hemorrhagic Disorder d/t Intrns Circ Anticoag,Antib,Inhib
 ;;^UTILITY(U,$J,358.3,4198,1,4,0)
 ;;=4^D68.318
 ;;^UTILITY(U,$J,358.3,4198,2)
 ;;=^340504
 ;;^UTILITY(U,$J,358.3,4199,0)
 ;;=R50.9^^20^191^13
 ;;^UTILITY(U,$J,358.3,4199,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4199,1,3,0)
 ;;=3^Fever,Unspec
 ;;^UTILITY(U,$J,358.3,4199,1,4,0)
 ;;=4^R50.9
 ;;^UTILITY(U,$J,358.3,4199,2)
 ;;=^5019512
 ;;^UTILITY(U,$J,358.3,4200,0)
 ;;=R53.81^^20^191^20
 ;;^UTILITY(U,$J,358.3,4200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4200,1,3,0)
 ;;=3^Malaise
 ;;^UTILITY(U,$J,358.3,4200,1,4,0)
 ;;=4^R53.81
 ;;^UTILITY(U,$J,358.3,4200,2)
 ;;=^5019518
 ;;^UTILITY(U,$J,358.3,4201,0)
 ;;=R53.83^^20^191^12
 ;;^UTILITY(U,$J,358.3,4201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4201,1,3,0)
 ;;=3^Fatigue
 ;;^UTILITY(U,$J,358.3,4201,1,4,0)
 ;;=4^R53.83
 ;;^UTILITY(U,$J,358.3,4201,2)
 ;;=^5019520
 ;;^UTILITY(U,$J,358.3,4202,0)
 ;;=R60.0^^20^191^10
 ;;^UTILITY(U,$J,358.3,4202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4202,1,3,0)
 ;;=3^Edema,Localized
 ;;^UTILITY(U,$J,358.3,4202,1,4,0)
 ;;=4^R60.0
 ;;^UTILITY(U,$J,358.3,4202,2)
 ;;=^5019532
 ;;^UTILITY(U,$J,358.3,4203,0)
 ;;=R60.1^^20^191^9
 ;;^UTILITY(U,$J,358.3,4203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4203,1,3,0)
 ;;=3^Edema,Generalized
 ;;^UTILITY(U,$J,358.3,4203,1,4,0)
 ;;=4^R60.1
 ;;^UTILITY(U,$J,358.3,4203,2)
 ;;=^5019533
 ;;^UTILITY(U,$J,358.3,4204,0)
 ;;=R60.9^^20^191^11
 ;;^UTILITY(U,$J,358.3,4204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4204,1,3,0)
 ;;=3^Edema,Unspec
 ;;^UTILITY(U,$J,358.3,4204,1,4,0)
 ;;=4^R60.9
 ;;^UTILITY(U,$J,358.3,4204,2)
 ;;=^5019534
 ;;^UTILITY(U,$J,358.3,4205,0)
 ;;=R63.4^^20^191^1
 ;;^UTILITY(U,$J,358.3,4205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4205,1,3,0)
 ;;=3^Abnormal Weight Loss
 ;;^UTILITY(U,$J,358.3,4205,1,4,0)
 ;;=4^R63.4
 ;;^UTILITY(U,$J,358.3,4205,2)
 ;;=^5019542
 ;;^UTILITY(U,$J,358.3,4206,0)
 ;;=Z79.4^^20^191^19
 ;;^UTILITY(U,$J,358.3,4206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4206,1,3,0)
 ;;=3^Long Term Use of Insulin,Current
 ;;^UTILITY(U,$J,358.3,4206,1,4,0)
 ;;=4^Z79.4
 ;;^UTILITY(U,$J,358.3,4206,2)
 ;;=^5063334
 ;;^UTILITY(U,$J,358.3,4207,0)
 ;;=Z79.01^^20^191^18
 ;;^UTILITY(U,$J,358.3,4207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4207,1,3,0)
 ;;=3^Long Term Use of Anticoagulants,Current
 ;;^UTILITY(U,$J,358.3,4207,1,4,0)
 ;;=4^Z79.01
 ;;^UTILITY(U,$J,358.3,4207,2)
 ;;=^5063330
 ;;^UTILITY(U,$J,358.3,4208,0)
 ;;=H61.23^^20^192^5
 ;;^UTILITY(U,$J,358.3,4208,1,0)
 ;;=^358.31IA^4^2
